Document:

<PAGE>

                                   Exhibit 4.1

                               CONTRACT AGREEMENT

This AGREEMENT shall be effective on this 16th day of November 2001 and is made
between Istanbul, Inc.("Consultant") and Max Development, Inc. d/b/a Image World
Media, Inc., a Colorado Corporation having offices at 15245 Shady Grove Road,
Suite 400 Rockville, Maryland 20850 ("Client").

1.0      PREMISES

         WHEREAS, the Consultant has expertise in the area of business
development, corporate strategy, joint ventures, media communications, mergers
and acquisitions; and

         WHEREAS, having reviewed the Consultant's background and experience,
the Client has made a determination as to the competency of Consultant to assist
the Company with such matters;

         NOW THEREFORE, in consideration of the premises, covenants and
conditions contained in this AGREEMENT, and intending to be legally bound, the
parties mutually agree as follows:

2.0      AUTHORITY AND RESPONSIBILITY OF CONSULTANT

2.1 Gregg Davis will be the consultant of record and will perform the services
listed in Section 2.2 below. No other individual will be substituted without the
express written permission of the Client.

2.2 The Consultant will use his best efforts to assist with the following:

         a)       Aiding in Client's corporate strategy and business planning,
                  and arranging meetings when appropriate;

         b)       Attending key meetings for Client for the purpose of business
                  development;

         c)       Providing assistance with regard to structuring of proposed
                  mergers and acquisitions by Client;

         d)       Liaising with Client's accountants and legal advisors when
                  necessary to assist with Client's business development;

         e)       All other services which the Consultant sees fit to render
                  under this AGREEMENT; and

<PAGE>

         f)       Consultant shall not be responsible for any fundraising on
                  behalf of Client, unless otherwise agreed to in writing by
                  Consultant.

3.0      AUTHORITY AND DUTIES OF CLIENT.

3.1 Client shall provide Consultant with all necessary information about the
company and will provide a representative to act as a liaison to the Consultant.

4.0      LEVEL OF EFFORT; TERM OF AGREEMENT

4.1 The term of this AGREEMENT is one year.

4.2 This AGREEMENT may be terminated by either party with 30 days written
notice.

4.3 The Consultant will use his best efforts throughout the term of the
AGREEMENT.

5.0      FEES AND TERMS OF SALE

5.1 Within 20 days of the signing of this AGREEMENT, the Consultant shall
receive 300,000 shares of Common Stock of Max Development, Inc. To the extent
that Form S-8 is available to register the Shares under the Securities Act of
1933, as amended, the Company will use its best efforts to register the issuance
of such shares on Form S-8. In the event that the Company files an SB-2 or
similar registration statement within one year of the closing, the Consultant
will be provided "piggyback" registration rights with respect to any shares not
already registered pursuant to Form S-8.

5.2 In addition, the Consultant shall receive reimbursement for all reasonable
out-of-pocket expenses incurred as a result of performing the services described
in Section 2.

5.3 Consultant shall return for cancellation any shares previously received in
connection with its services to Image World Media, Inc.

6.0      PROPRIETARY INFORMATION

6.1 The Consultant agrees to safeguard confidential information of Client and
will not disclose or permit the use or disclosure of any such information,
except as authorized in advance by Client in writing. The Consultant further
agrees to surrender all confidential data to Client either on request,
cancellation, or termination of this AGREEMENT and will not retain copies,
notes, or memoranda of such data. The obligations specified in this section
shall be deemed to survive the termination of this AGREEMENT.

7.0      RELATIONSHIP OF PARTIES

7.1 This AGREEMENT does not create an employer-employee or agent-servant
relationship between the parties. At all times under this AGREEMENT the
Consultant shall be considered an independent contractor.

<PAGE>

7.2 Consultant shall not be responsible for any obligation or liability incurred
or assumed by the Client or its employees, affiliates, representatives, agents,
or subcontractors and the Client hereby indemnifies and holds Consultant
harmless from any claim arising from the acts or omissions of such persons.

8.0      MODIFICATIONS; ENTIRE AGREEMENT

8.1 This writing contains the entire AGREEMENT of the parties. No
representations were made or relied upon by any party other than those expressly
set forth herein. No agent, employee, or representative of a party is empowered
to alter or modify any of the terms in this AGREEMENT unless such modification
is done in writing and signed by the signatories below, or other authorized
representatives designated, in writing, by the respective parties. The parties
specifically agree that this AGREEMENT supersedes and replaces any prior
agreement between the parties, including but limited to, any agreement between
the Consultant and Client's wholly owned subsidiary, Image World Media, Inc.

9.0      SEVERABILITY

9.1 Any provision of this AGREEMENT that is invalid, illegal or unenforceable in
any jurisdiction shall, as to that jurisdiction, be ineffective to the extent of
such invalidity, illegality, or unenforceability, without affecting in any way
the remaining provisions hereof in such jurisdiction or rendering that or any
other provision of this AGREEMENT invalid, illegal, or unenforceable in any
other jurisdiction.

10.0     WAIVERS

10.1 Any waiver by a party to any term or condition of this AGREEMENT by the
other party shall not affect or impair the waiving party's right with respect to
any subsequent act or omission of the same type, nor shall it be deemed to waive
any other right under this AGREEMENT; nor shall any delay or omission of a party
to exercise any right arising under this AGREEMENT affect or impair such party's
rights as to the same or any future delay or omission; nor shall the failure of
a party to this AGREEMENT to require or exact full and complete compliance with
any one or more of the provisions of this AGREEMENT be construed as in any
manner changing such provision or provisions.

11.0     AUTHORITY TO ACT

11.1 The parties hereto warrant and represent that they have the full power and
authority to enter into this AGREEMENT and to consummate the transactions
contemplated hereby and have been duly authorized to execute this AGREEMENT.

12.0     NOTICES

12.1 All notices, purchase orders, and other communications contemplated under
this AGREEMENT shall be in writing and shall be either personally delivered, or
transmitted by certified mail, facsimile transmission, wire, or other device
reasonably calculated to effect delivery of documents within five (5) business
days. Unless otherwise agreed to by all the parties, such notices, orders, and
communications shall be sent, as appropriate, to the parties at the addresses
noted below:

<PAGE>

If to Consultant:

Istanbul  Inc.
305 West 50th Street, Suite 2K
New York, NY 10019

Attn:    Gregg Davis

If to the Client:

Image World Media, Inc.
15245 Shady Grove Road, Suite 400
Rockville, Maryland 20850

13.0     CONROLLING LAW AND DISPUTE RESOLUTION

13.1 This AGREEMENT shall be interpreted, controlled, and enforced in accordance
with the substantive laws of the State of Maryland.

13.2 Each party shall bear its own expenses in any litigation conducted under
this section.

13.2 Any controversy or claim arising out of or relating to this AGREEMENT, or
breach of this AGREEMENT is to be settled by arbitration in Rockville, Maryland
in accordance with the Commercial Arbitration Rules of the American Arbitration
Association, and judgment on the award rendered by the arbitrators may be
entered in any court having jurisdiction. There must be three arbitrators, one
to be chosen directly by each party at will and the third arbitrator to be
selected by the two arbitrators so chosen. Each party will pay the fees of the
arbitrator he or she selects and his or her own attorneys, and the expenses of
his or her witnesses and all other expenses connected with presenting his or her
case. Other costs of the arbitration, including the cost of any record or
transcripts of the arbitration, administrative fees, the fee of the third
arbitrator, and all other fees and costs, will be borne equally by the parties.

14.0     TERMINATION

14.1 This AGREEMENT shall be deemed terminated upon the occurrence of any one or
more of the following events:

     (a) A party commits a breach of one or more material terms and conditions
of this AGREEMENT and the nonbreaching party elects to terminate this AGREEMENT;

     (b) In the Opinion of the Client, the Consultant fails to put forth a
satisfactory level of effort in performing the duties described in Section 2.0;

<PAGE>

     (c) A party becomes insolvent, or subject to a petition in bankruptcy, or
is placed under the control of a receiver, liquidator, or committee of
creditors; or

     (d) Upon mutual consent of the parties.

14.2 Termination of this Agreement for any reason shall not effect the
compensation to be paid to consultant pursuant to Section 5.

IN WITNESS WHEREFORE, the parties hereto have duly executed this Contract for
Consulting Services.

Consultant

ISTANBUL INC.

BY: /s/ Gregg Davis
   --------------------------
Printed Name: Gregg Davis

MAX DEVELOPMENT INC.

BY: /s/ Mark Elenowitz
   --------------------------
Printed Name: Mark Elenowitz<PAGE>

                                                                    Exhibit 10.7

                           Evaluation of SafetyScopeTM
               as a Device for Detecting Fatigue in the Workplace

                              Phase 1: Pilot Study

                         Proposal to Eye Dynamics, Inc.

                                  Submitted by

                Circadian Technologies, Inc., Cambridge, MA (CTI)

1.0 BACKGROUND

Eye Dynamics, Inc. has developed a device that quickly and inexpensively detects
substance impairment by passively scanning the subject's pupil. While this
device has been validated for the use in the detection of substance impairment,
it has not been tested for detecting fatigue-induced impairment.

The link between pupillometric measures and alertness has been demonstrated in
various studies (e.g., Lowenstein et al. 1963, Yoss et al. 1969, Yoss et al.
1970, Newman et al. 1981, Schmidt et al. 1981, Schmidt and Fortin 1982,
Kollarits et al. 1983, Schmidt and Schrier 1983, Newman and Broughton 1991,
Lichstein and Johnson 1994, Mc Laren et al. 1992, Wilhelm et al. 1996, Wilhelm
et al. 1998). Most of these studies used pupillograms (recording of pupil
diameter) for assessing hippus (oscillation of pupil diameter) and severity and
onset of miosis (pupil constriction). Typically, pupillograms are recorded
during a 10-15 min interval. Little research has been performed on developing
and validating shorter pupillometric tests. Circadian Technologies has actively
conducted product evaluation studies of both pupillogram recordings (e.g., Mayo
pupillometric system) and shorter pupillometric tests (e.g., FIT device). These
research projects involved laboratory studies in CTI's Alertness Testbed, as
well as field studies. The results of these studies indicate that certain
pupillometric measures may have potential as alertness indicators. The
development of a pupil-based fatigue detection device is therefore a realistic
undertaking, and an inexpensive device for accurate and fast testing has a wide
range of potential applications.

                                   Page 1 of 5

<PAGE>

                        PROPOSAL FOR PHASE I PILOT STUDY

Eye Dynamics wishes to evaluate its SafetyScopeTM device as a fatigue detection
device. Before introducing such a device to the market, it is essential to
scientifically validate and document the system's sensitivity, accuracy and
reliability.

This proposal addresses Phase 1: Pilot Testing. This phase, based on data
collection from a small subject group, will serve as an initial proof-of-concept
study. It will help refine the study design, methods and pupil test device for a
subsequent full-scale validation study.

SCOPE OF WORK OF PHASE I PILOT STUDY:

1.       Study Preparation:
         -----------------
         Study preparation includes the delivery and set-up of the SafetyScopeTM
         device, training of CTI staff in the use of the device, subject
         recruitment/screening, and final study approval by CTI's Institutional
         Review Board.

         Subjects' recruitment criteria include a screening process involving
         questionnaires about health and sleep issues. Only subjects with no
         history of seizures, blood pressure abnormalities, heart problems, etc.
         will be included. In addition, subjects will be required to be
         medication free (including any over-the counter products) for the week
         prior to the experiment. The recruitment criteria will also include the
         requirement that subjects have not used an illegal substance for the
         prior month. Eye Dynamics (at their expense) may require a random,
         on-site, urine-screen. Subjects are not to be entered into the study if
         they show positive on the urine-screen for any illegal substances.
         Typical alcohol consumption should be at moderate levels (4-6
         drinks/week), but the subject should abstain from any alcohol for the
         week prior.

         CTI will ask the recruited subjects to follow their regular sleep
         routine during the week prior to the experiment. In order to verify
         their sleep pattern, CTI will ask them to complete a sleep log for one
         week prior to the experiment. They will also wear a wrist activity
         monitor for one week in order to objectively confirm the subjective
         sleep log information. The sleep pattern information will be used to
         predict the alertness pattern for the experimental day and night by
         means of the computerized CAS (Circadian Alertness Simulation) system.

2.       Conduct Evaluation Tests:
         ------------------------
         The evaluation study will be conducted in CTI's Alertness Testbed. Six
         (6) subjects will participate in one (1) experimental afternoon and
         night each. The overnight test protocol will consist of a series of
         nine test sessions starting in the early afternoon and repeated every
         two hours until the next morning (no sleep allowed). A

                                   Page 2 of 5

<PAGE>

         SafetyScopeTM baseline (non-impaired initial trial) will be established
         prior to the beginning of the test protocol. During each test session,
         subjects will undergo the same battery of tests. Test sessions will be
         conducted at regular intervals with the first test session starting
         during daytime and the last test session starting in the early morning
         of the subsequent day. The test protocol includes (on a bi-hourly
         basis):

         a)       Subjective sleepiness test
         b)       SafetyScopeTM task
         c)       Driving task
         d)       Subjective sleepiness test
         e)       SafetyScopeTM test
         f)       Subjective sleepiness test
         g)       Performance vigilance test
         h)       Subjective sleepiness test
         i)       Break

         This overnight protocol (subjects are not allowed to sleep during the
         experiment) enables the testing of subjects at various alertness
         levels, which will be necessary for the validation of the fatigue test
         device.

         The effectiveness of the SafetyScopeTM will be assessed by comparison
         with other alertness measures (EEG & EOG recordings, subjective
         measures, behavioral sleepiness signs, and performance measures).
         Evaluation of the SafetyScopeTM will only include the "YES/NO"
         impairment output parameter (determined from the automatic comparison
         of a SafetyScopeTM test to the subjects SafetyScopeTM baseline) and the
         correlation of this single parameter with the alertness measures listed
         above.

         Data from CTI's CAS will be made available to Eye Dynamics. This may be
         used to 'weight 'Eye Dynamics' analysis algorithm as a means enhance
         the fatigue detection capability of the SafetyScopeTM. The use of this
         data in no way confers rights for the usage of the CAS model algorithm
         for any purpose beyond this pilot test; as well, Eye Dynamics agrees
         not to reverse engineer, disassemble, or otherwise reconstruct the CAS
         model algorithm.

3.       Data Processing:
         ----------------
         CTI Research & Development personnel will process the data streams
         collected by the various components of the alertness testbed, as well
         as the SafetyScopeTM system.

                                   Page 3 of 5
<PAGE>

4.       Assessment of SafetyScopeTM Device:
         -----------------------------------
         The impairment detection function of the SafetyScopeTM device will be
         evaluated against the scientifically proven alertness measures employed
         as part of the CTI Alertness Testbed.

5.       Report Result:
         --------------
         The results of the Phase I pilot study will be reported to Eye Dynamics
         in the form of a power point summary presentation and a written report.

6.       Define Future Phases of Evaluation:
         -----------------------------------
         CTI will work with Eye Dynamics to define Phase 2 Validation Study of
         this project, which will represent a continuation of the Phase I Pilot
         Study.

RESOURCES:
Circadian Technologies will provide a team of qualified researchers and
engineers with extensive experience in the fields of sleep physiology, fatigue,
chronobiology, and applications in shiftwork and transportation. CTI's Circadian
Alertness Laboratory will also provide test facilities, driving simulator and
physiological test equipment as well as data analysis technologies.

TIMELINE:
The project will be completed in a three-month period, commencing in
mid-December 2000, with a target completion date of early March 2001. CTI
proposes to start subject recruitment and pre-screening immediately. As well,
CTI proposes that the evaluation tests between conducted between January 1, 2001
and January 22, 2001. Data processing and statistical analysis will be conducted
in February 2001, with a final report presented to Eye Dynamics in early March
2001.

BUDGET:
This pilot study is designed for a total of six experimental overnight test days
(one test day per subject). Based on CTI's fee of $6,500 per subject test day,
the total budget of this pilot study will be $39,000. This is due and payable
(net 15) in two (2) installments of $19,500. The first installment is billable
at the start of the project and the final invoice is pre-billed and payable upon
delivery of the final report. This fee includes all expenses related to study
setup and preparation, data collection and data analysis. Travel and shipping
costs are not included.

TERMS AND CONDITIONS:

1.       TRAVEL: Quoted costs exclude any travel expenses that may be incurred
         by CTI staff as part of this project (i.e. travel to Eye Dynamics for
         training in device use, if necessary) and these will be billed
         separately. All travel and related expenses must be pre-approved by Eye
         Dynamics.

                                  Page 4 of 5
<PAGE>

2.       SHIPPING: Quoted costs exclude costs of shipping equipment.

3.       EQUIPMENT: CTI will provide the physiological testing and analysis
         equipment for use in the study at no charge. The SafetyScopeTM device
         to be tested will be loaned by Eye Dynamics to CTI at no cost.

4.       CONFIDENTIALITY: CTI agrees not to disclose or publish any results
         arising from the Phase I Pilot Project without the prior written
         consent of Eye Dynamics.

The undersigned accept and approve the scope of work, timeline, budget, terms
and conditions stated herein.

CIRCADIAN TECHNOLOGIES, INC.                     EYE DYNAMICS, INC.

/s/                                              /s/
------------------------------                   ------------------------------
Signature                                        Signature

Dr. Martin Moore-Ede                             Ron Waldorf
------------------------------                   -------------------------------
Name                                             Name

President and CEO                                Chairman
------------------------------                   -------------------------------
Title                                            Title

December 19, 2000                                December 19, 2000
------------------------------                   -------------------------------
Date                                             Date

                                   Page 5 of 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00032-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00032-of-00352.parquet"}]]